Del(5q) is associated with clinical and histological parameters in small cell neuroendocrine lung carcinoma

International Journal of Surgical Pathology

Volumn 16, Issue 4, 2008, Pages 419-423

  Hartel, Paul H ^a,b   Shackelford, Amy L ^a   Hartel, James V ^a   Wenger, Sharon L ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b Davis Memorial Hospital   (United States)

Author keywords

5q; Chromosome; Lung cancer; Neuroendocrine; Small cell; Spindle cell

Indexed keywords

EOSIN; HEMATOXYLIN; MUCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL STRUCTURE; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FIBROSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MALE; MITOSIS; NEUROSECRETORY CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN SECRETION; SMALL CELL NEUROENDOCRINE LUNG CARCINOMA; SPINDLE CELL; SYMPTOM; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR NECROSIS;

AGED; CARCINOMA, SMALL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING;

EID: 52149116535     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896908318935     Document Type: Article

References (19)

1. Travis WD, Brambilla E., Muller-Hermelink HK, Harris CC World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus, and Heart. Lyon, France: IARC Press; 2004: 344.
2. Fong KM, Sekido Y., Minna JD Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg. 1999 ; 118: 1136-1152.
3. Girard L., Zochbauer-Muller S., Virmani AK, Gazdar AF, Minna JD Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000 ; 60: 4894-4906.
4. Miura I., Graziano SL, Cheng JQ, Doyle LA, Testa JR Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. Cancer Res. 1992 ; 52: 1322-1328.
5. Hosoe S., Ueno K., Shigedo Y., et al. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res. 1994 ; 54: 1787-1790.
6. Schwendel A., Langreck H., Reichel M., et al. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer. 1997 ; 74: 86-93.
7. Onuki N., Wistuba II, Travis WD, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer. 1999 ; 85: 600-607.
8. Whang-Peng J., Kao-Shan CS, Lee EC, et al. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science. 1982 ; 215: 181-182.
9. Walch AK, Zitzelsberger HF, Aubele MM, et al. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol. 1998 ; 153: 1089-1098.
10. Ullmann R., Petzmann S., Sharma A., Cagle PT, Popper HH Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Hum Pathol. 2001 ; 32: 1059-1063.
11. Welborn J., Jenks H., Taplett J., Walling P. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations. Cancer Genet Cytogenet. 2004 ; 155: 33-41.
12. Ashman JN, Brigham J., Cowen ME, et al. Chromosomal alterations in small cell lung cancer revealed by multicolour fluorescence in situ hybridization. Int J Cancer. 2002 ; 102: 230-236.
13. Tamura K., Miwa W., Maruyama T., Sekiya T., Murakami, Y. Homozygous deletion on the chromosomal region 5q12.3 in human lines of small-cell lung cancers. J Hum Genet. 2002 ; 47: 348-354.
14. Mendes-da-Silva P., Moreira A., Duro-da-Costa J., Matias D., Monteiro C. Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma. Mol Pathol. 2000 ; 53: 184-187.
15. Goguel AF, Fouquet F., Duverger A., et al. Evolution of chromosomal alterations and biologic features in two small cell lung carcinoma cell lines established from one patient during the course of the disease. Cancer Genet Cytogenet. 1995 ; 80: 47-54.
16. Smith JS, Perry A., Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 2000 ; 18: 636-645.
17. Morel P., Hebbar M., Lai JL, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia. 1993 ; 7: 1315-1323.
18. Grimwade D., Walker H., Oliver F., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998 ; 92: 2322-2333.
19. Dohner H., Stilgenbauer S., Benner A., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000 ; 343: 1910-1916.